Search
Propanc Biopharma Ord Shs
PPCBAdd to Watchlist
1.460USD
-0.040-2.66%
Market hours （ET）Quotes delayed by 15 min
19.46MMarket Cap
0.00P/E TTM
Propanc Biopharma Ord Shs Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-371.22
73.87%
Analyst Rating
--
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the Earnings Per Share (EPS) of Propanc Biopharma Ord Shs?
According to Propanc Biopharma Ord Shs's FY2025 earnings report, its Earnings Per Share (EPS) was -371.22, with a year-on-year change of 73.87.
What is the debt-to-asset ratio of Propanc Biopharma Ord Shs?
According to Propanc Biopharma Ord Shs's FY2025 earnings report, its debt-to-asset ratio was 8.49, with a year-on-year change of -99.34.
What is the Return on Assets (ROA) of Propanc Biopharma Ord Shs?
According to Propanc Biopharma Ord Shs's FY2025 earnings report, its Return on Assets (ROA) was -598.08, with a year-on-year change of 78.20.